Zhou Y, Sharma J, Ke Q, Landman R, Yuan J, Chen H, et al
Le Foll C, et al
Sakai, Y., Miyauchi, K., Kimura, S
Insulin may also suppress lipolysis in 3T3-L1 adipocytes through downregulation of desnutrin/ATGL mRNA (59)
If cagrilintides clinical benefit rests primarily on sustained central satiety rather than on persistent gastric slowing, then the titles framing cagrilintide as a gastric-emptying and postprandial-metabolism agent describes the compounds acute pharmacology more accurately than its chronic steady-state behavior
Cautions: If you are pregnant, nursing, have any health condition, or are taking any medication, consult your healthcare professional before using this product